Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evgen Pharma PLC (GB:TCF)
LSE:TCF
Evgen Pharma (TCF) Share Price & Analysis
1 Followers
TCF Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range0.60p - 3.40p
Previous Close0.78p
Volume3.87M
Average Volume (3M)1.33M
Market Cap
£3.31M
Enterprise Value-1.69M
Total Cash (Recent Filing)£5.00M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta-0.48
Next Earnings
Dec 04, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding427,346,895
10 Day Avg. Volume1,954,824
30 Day Avg. Volume1,327,379
Standard Deviation0.25
R-Squared0.05
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)9668.48
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Evgen Pharma News
PremiumCompany Announcements
TheraCryf plc AGM Success and Strategic Focus
PremiumCompany Announcements
Investor Ups Stake in Theracryf PLC
PremiumCompany Announcements
Theracryf PLC Announces Major Shareholding Changes
PremiumCompany Announcements
TheraCryf’s SFX-01 Shows Promise in Cancer Treatment
PremiumCompany Announcements
TheraCryf Schedules AGM, Shares Annual Report
PremiumCompany Announcements
First Equity Adjusts Stake in Theracryf PLC
PremiumCompany Announcements
TheraCryf Unveils Promising Glioblastoma Treatment Updates
PremiumCompany Announcements
Evgen Pharma Sees Major Voting Rights ShiftOptions Prices
Currently, No data available
---
Ownership Overview
2.65% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
97.35% Public Companies and
Individual Investors
TCF FAQ
What was Evgen Pharma PLC’s price range in the past 12 months?
Evgen Pharma PLC lowest share price was 0.60p and its highest was 3.40p in the past 12 months.
What is Evgen Pharma PLC’s market cap?
Currently, no data Available
When is Evgen Pharma PLC’s upcoming earnings report date?
Evgen Pharma PLC’s upcoming earnings report date is Dec 04, 2024 which is in 139 days.
How were Evgen Pharma PLC’s earnings last quarter?
Evgen Pharma PLC released its earnings results on May 28, 2024. The company reported -0.006p earnings per share for the quarter, missing the consensus estimate of N/A by -0.006p.
Is Evgen Pharma PLC overvalued?
According to Wall Street analysts Evgen Pharma PLC’s price is currently Overvalued.
Does Evgen Pharma PLC pay dividends?
Evgen Pharma PLC does not currently pay dividends.
What is Evgen Pharma PLC’s EPS estimate?
Evgen Pharma PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Evgen Pharma PLC have?
Evgen Pharma PLC has 427,346,900 shares outstanding.
What happened to Evgen Pharma PLC’s price movement after its last earnings report?
Evgen Pharma PLC reported an EPS of -0.006p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.667%.
Which hedge fund is a major shareholder of Evgen Pharma PLC?
Currently, no hedge funds are holding shares in GB:TCF
---
Evgen Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-72.80%
12-Months-Change
Fundamentals
Return on Equity
-81.67%
Trailing 12-Months
Asset Growth
-50.40%
Trailing 12-Months
Company Description
Evgen Pharma PLC
Evgen Pharma PLC is a UK-based clinical-stage drug development company. The company is focused on the development of sulforaphane-based compounds. Its core technology is Sulforadex, which synthesis and stabilizes the naturally occurring compound sulforaphane. Geographically, it operates only in the United Kingdom. It is engaged in the treatment of breast cancer and Subarachnoid Haemorrhage.
---
Technical Analysis
---